Paul Chi-Lui Ho

机构：Monash University Malaysia

发表论文 6 篇 · 总被引 229 次 · h-index 6

代表论文

• Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy (2025 · Cytokine & Growth Factor Reviews · 被引 100)
• Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development (2016 · Oncotarget · 被引 69)
• Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers (2024 · Pharmacological Research · 被引 21)
• Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine (2025 · Frontiers in Pharmacology · 被引 19)
• Blood-based biomarkers for Alzheimer's disease: Advances in early detection and monitoring of age-related neurodegeneration (2026 · Ageing Research Reviews · 被引 12)
• Antibody-conjugated polymer nanoparticles for brain cancer (2025 · Drug Delivery and Translational Research · 被引 8)